AMH Test for Ovarian Reserve: Predicting Fertility Potential

AMH testing is a crucial tool for evaluating ovarian reserve and predicting fertility outcomes. Anti-Müllerian Hormone (AMH) levels correlate with egg quantity and response to treatments, offering insights earlier than FSH tests. Patients undergoing fertility evaluations should prioritize AMH testing for personalized treatment plans.

Key Takeaways

AMH Testing as a Standard Fertility Evaluation Tool

AMH testing is now a core part of fertility assessments at Shady Grove Fertility. Combined with FSH, estradiol, and antral follicle count, AMH provides a comprehensive view of ovarian reserve, enabling tailored treatment strategies for egg freezing, IVF, or other therapies.

Impact of Contraceptives on AMH Levels and Fertility Testing

Continuous contraceptive use (pills, patches, vaginal rings) significantly lowers AMH levels. Women on hormonal birth control should retest AMH after discontinuing use for a month to ensure accurate ovarian reserve assessment.

AMH’s Role in Tailoring Fertility Treatments and Medication Dosing

AMH results guide individualized medication dosing and treatment plans, outperforming age, BMI, or FSH as predictors of ovarian response. This precision optimizes success rates for procedures like IVF and egg freezing.

Source: Read full article